Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant global health concern, especially in developing countries. The challenge of antibiotic resistance and the need for effective management strategies necessitates an in-depth analysis of current approaches.
Early and accurate diagnosis is crucial in managing enteric fever. Conventional culture methods, though gold standard, are time-consuming and often yield low sensitivity. Rapid diagnostic tests, such as serological and molecular methods, offer promise for timely detection and management.
The emergence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) strains poses a significant challenge. Fluoroquinolones, once first-line therapy, face increasing resistance. Third-generation cephalosporins and azithromycin are now often preferred, but vigilance for emerging resistance is necessary.
Preventive measures, such as vaccination, play a crucial role in controlling enteric fever. The WHO recommends the typhoid conjugate vaccine (TCV) for children over six months in endemic regions. Additionally, the live oral Ty21a vaccine and the Vi polysaccharide vaccine offer alternatives for specific populations.
Control measures include improving sanitation, safe drinking water supply, and food safety. Case detection and contact tracing, coupled with antimicrobial stewardship, can limit the spread of resistant strains.
Enteric fever management requires a multi-faceted approach, combining early diagnosis, effective treatment, vaccination, and stringent public health measures. The rise of antibiotic resistance underscores the importance of ongoing research into novel therapies and vaccines. As we strive for better management strategies, collaboration between clinicians, microbiologists, and public health officials is essential.
1.
Primary Sjögren's syndrome patients' B-Cell Stimulating Factors are associated with the growth of lymphomas.
2.
Long-Acting Interferon Therapy Approved for ET
3.
More cancer cases in areas where incarceration rates are high: Study
4.
Firefighters who eat better can combat cancer.
5.
Second opinions don't significantly delay breast cancer treatment
1.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
2.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
3.
Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment
4.
Deep Learning Fluorescence Imaging for Oral Cancer Surgery: In Silico Depth Quantification
5.
Regenerative Reprogramming of Dormant Cellular Niches Following Cancer Therapy
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Hands-on Workshop: Hematology
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation